Literature DB >> 28855493

Clinical characteristics of 17 adult patients with epidemic myalgia associated with human parechovirus type 3 infection.

Tatsushi Yamakawa1, Katsumi Mizuta2, Katsurou Kurokawa1, Hikaru Nagasawa1, Takahiro Yamada3, Emiko Suzuki4, Manabu Wada1.   

Abstract

We investigated 17 adult cases (14 males and 3 females) of myalgia induced by human parechovirus type 3 (HPeV3) infection, treated during the summers of 2008, 2011, 2014, and 2016. The patients were aged between 21 and 50 years. The limbs and trunk of all patients were affected, and severe myalgia, muscle weakness, and decreased grip strength were observed. In addition to myalgia and muscle weakness, symptoms included fever in 14 (82%), upper respiratory inflammation in 8 (47%), gastroenteritis in 4 (24%), and scrotal pain in 4 (29% of males) patients. Tendon reflexes were preserved, and serum creatine kinase level increased in all but 1 patient. Spinal MRI was performed for 3 patients, with normal results. Musculoskeletal MRI scans showed abnormal signals in the femoral muscles in 2 of 5 patients. In a nerve conduction test, the frequency of F wave appearance in the median nerve was 40% or less in 5 of 9 patients, and repeater F waves were seen in 2 patients. Of these, 7 patients had infants in their families, and developed fever around the same time; they may have been infected by these infants. All patients recovered within 1-2 weeks. HPeV3 infection is characterized by severe myalgia, and is frequently observed in summer every 2-3 years.

Entities:  

Keywords:  HPeV3-M; HPeV3-associated myalgia/myositis; epidemic myalgia; human parechovirus type 3; myositis

Mesh:

Year:  2017        PMID: 28855493     DOI: 10.5692/clinicalneurol.cn-001035

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  3 in total

Review 1.  Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: a case report and brief review of the literature.

Authors:  Kiwamu Nakamura; Kyoichi Saito; Yasuka Hara; Tetsuji Aoyagi; Kadzuhiro Kitakawa; Yoshinobu Abe; Hiromu Takemura; Fumihito Ikeda; Mitsuo Kaku; Keiji Kanemitsu
Journal:  BMC Infect Dis       Date:  2018-08-07       Impact factor: 3.090

2.  Parechovirus A prevalence in adults in The Netherlands.

Authors:  Lieke Brouwer; Katja C Wolthers; Dasja Pajkrt
Journal:  Arch Virol       Date:  2020-02-14       Impact factor: 2.574

3.  Epidemic Myalgia Associated with Human Parechovirus Type 3 Infection.

Authors:  Moemi Miyazaki; Kenta Hara; Tomofumi Takayoshi; Tetsuya Kawase; Yasushi Nakagawa; Takashi Arai; Takeshi Sugimoto; Katsuhito Nishiyama; Gabriel Gonzalez; Nozomu Hanaoka; Tsuguto Fujimoto; Yoshiro Yasutomo; Koichi Yokono
Journal:  Intern Med       Date:  2019-10-31       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.